SWM
EBS icon

SHP Wealth Management’s Emergent Biosolutions EBS Stock Holding History

SHP Wealth Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5
Closed -$62 – 1847
2025
Q4 		$62 Buy
+5
New +$54 ﹤0.01% 1520

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SHP Wealth Management's EBS Position: Q1 2026 in Review

SHP Wealth Management sold out of Emergent Biosolutions (EBS) in Q1 2026, closing a stake of 5 shares — an estimated $62 sold.

SHP Wealth Management first reported a position in EBS in Q4 2025 and held it in 1 quarter. The position peaked at $62 in Q4 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • SHP Wealth Management reported no remaining Emergent Biosolutions position as of Q1 2026 after selling out during the quarter.
  • SHP Wealth Management sold 5 Emergent Biosolutions shares in Q1 2026, an estimated $62.
  • SHP Wealth Management first reported a position in Emergent Biosolutions in Q4 2025 and held it in 1 quarter.
  • SHP Wealth Management's Emergent Biosolutions position peaked at $62 in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.